Roche's Sequencing Business Grows 12 Percent YTD as Applied Science Sales Shrink in Q3
October 19, 2010
Roche's Sequencing Business Grows 12 Percent YTD as Applied Science Sales Shrink in Q3
Roche said it has seen "robust uptake" in the European Union and Asia Pacific for the 454 GS Junior sequencer, a benchtop sequencer launched in May that is geared at small laboratories.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roche and Fluidigm to Co-Market 454's Sequencers, Fluidigm's Multiplexed PCR Arrays
October 19, 2010 / In Sequence - Roche NimbleGen Array Sales Rise 44 Percent in '09
February 9, 2010 / BioArray News - In Applied Science Restructuring, Roche Exits Microarrays, Bundles 'Sequencing Solutions,' R&D
June 12, 2012 / In Sequence - 454 Attributes Decline in Q2 Revenues to Delays from Customers Awaiting GS FLX+ Upgrade
July 26, 2011 / In Sequence - Paired Ends
July 19, 2011 / In Sequence